We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Paratek Pharmaceuticals Opens New Corporate Headquarters in Boston
News

Paratek Pharmaceuticals Opens New Corporate Headquarters in Boston

Paratek Pharmaceuticals Opens New Corporate Headquarters in Boston
News

Paratek Pharmaceuticals Opens New Corporate Headquarters in Boston

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Paratek Pharmaceuticals Opens New Corporate Headquarters in Boston"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Paratek Pharmaceuticals, Inc. has opened its new corporate headquarters in Boston at 75 Park Plaza.

"This move comes at an important time for Paratek, as we have recently initiated a global Phase 3 program for our lead antibiotic compound, omadacycline. With two important products in Phase 3 clinical studies, we are now preparing for the next phase of our growth as a biopharmaceutical company," said Michael Bigham, Chairman and Chief Executive Officer, Paratek. "The Company takes pride in its origins as a Boston-based biopharmaceutical company, and we look forward to our continued growth here in Boston."

The address of the new headquarters is 75 Park Plaza, 4th floor, Boston, MA 02116. Paratek was previously located at 75 Kneeland Street in Boston. In June Paratek opened a second office location in the Philadelphia area.

Advertisement